Perfluorobutane sulfonate exposure disrupted human placental cytotrophoblast cell proliferation and invasion involving in dysregulating preeclampsia related genes
- We reported that maternal PFBS, an emerging pollutant, exposure is positively associated with preeclampsia which can result from aberrant trophoblasts invasion and subsequent placental ischemia. In this study, we investigated the effects of PFBS on trophoblasts proliferation/invasion and signaling pathways. We exposed a human trophoblast line, HTR8/SVneo, to PFBS. Cell viability, proliferation, and cell cycle were evaluated by the MTS assay, Ki-67 staining, and flow cytometry, respectively.
- We assessed cell migration and invasion with live-cell imaging-based migration assay and matrigel invasion assay, respectively. Signaling pathways were examined by Western blot, RNA-seq, and qPCR. PFBS exposure interrupted cell proliferation and invasion in a dose-dependent manner. PFBS (100 μM) did not cause cell death but instead significant cell proliferation without cell cycle disruption. PFBS (10 and 100 μM) decreased cell migration and invasion, while PFBS (0.1 μM) significantly increased cell invasion but not migration.
- Further, RNA-seq analysis identified dysregulated HIF-1α target genes that are relevant to cell proliferation/invasion and preeclampsia, while Western Blot data showed the activation of HIF-1α, but not Notch, ERK1/2, (PI3K)AKT, and P38 pathways. PBFS exposure altered trophoblast cell proliferation/invasion which might be mediated by preeclampsia-related genes, suggesting a possible association between prenatal PFBS exposure and adverse placentation.
Jo-1 Antigen |
|||
| MBS318014-5x1000Units | MyBiosource | 5x1000Units | EUR 6020 |
Jo-1 Antigen |
|||
| MBS318130-02mg | MyBiosource | 0.2mg | EUR 1275 |
Jo-1 Antigen |
|||
| MBS318130-5x02mg | MyBiosource | 5x0.2mg | EUR 5490 |
Jo-1 Antigen Antibody |
|||
| abx022693-2ml | Abbexa | 2 ml | EUR 961.2 |
Jo-1 Antigen Antibody |
|||
| abx022693-400l | Abbexa | 400 µl | Ask for price |
Jo-1 Antigen Antibody |
|||
| abx022693-80l | Abbexa | 80 µl | EUR 987.5 |
Jo-1 Antigen Protein |
|||
| abx069873-1000Units | Abbexa | 1000 Units | EUR 1813.2 |
Jo-1 Antigen Protein |
|||
| abx069874-02mg | Abbexa | 0.2 mg | EUR 1312.8 |
Jo-1 Antigen Protein |
|||
| abx069875-100ug | Abbexa | 100 ug | EUR 718.8 |
Jo-1 Antigen Protein |
|||
| abx069873-1g | Abbexa | 1 g | Ask for price |
Jo-1 Antigen Protein |
|||
| abx069873-250mg | Abbexa | 250 mg | EUR 1862.5 |
Jo-1 Antigen Protein |
|||
| abx069873-5g | Abbexa | 5 g | Ask for price |
Jo-1 Antigen Protein |
|||
| abx069874-500g | Abbexa | 500 g | EUR 1725 |
Jo-1 Antigen, Recombinant |
|||
| MBS319005-01mg | MyBiosource | 0.1mg | EUR 1675 |
Jo-1 Antigen, Recombinant |
|||
| MBS319005-5x01mg | MyBiosource | 5x0.1mg | EUR 7290 |
Astrovirus Antigen (Type 1) |
|||
| AS02-1000 | The Native Antigen Company | 1.0 | EUR 1654.65 |
|
Description: A concentrated source of Astrovirus particles and Astrovirus proteins from a lysate of host cells. |
|||
Astrovirus Antigen (Type 1) |
|||
| AS02-200 | The Native Antigen Company | 0.2 | EUR 442.69 |
|
Description: A concentrated source of Astrovirus particles and Astrovirus proteins from a lysate of host cells. |
|||
Canine Adenovirus 1 Antigen |
|||
| NAT41587-100 | The Native Antigen Company | 0.1 | EUR 391.66 |
|
Description: Canine Adenovirus Type 1, produced in A-72 cells. |
|||
Herpes Simplex Virus 1 Antigen |
|||
| HS105-1000 | The Native Antigen Company | 1.0 | EUR 1178.79 |
|
Description: HSV-1 particles from a cell lysate are purified by sucrose gradient ultracentrifugation. |
|||
Herpes Simplex Virus 1 Antigen |
|||
| HS105-200 | The Native Antigen Company | 0.2 | EUR 294.7 |
|
Description: HSV-1 particles from a cell lysate are purified by sucrose gradient ultracentrifugation. |
|||
Canine Adenovirus 1 and 2 Antigen |
|||
| NAT41589-100 | The Native Antigen Company | 0.1 | EUR 391.66 |
|
Description: A mixture of Canine Adenovirus Type 1 and Type 2, produced in A-72 cells. |
|||
Herpes Simplex Virus 1 Lysate Antigen |
|||
| HS104-1000 | The Native Antigen Company | 1.0 | EUR 270.46 |
|
Description: A high concentration of HSV-1 particles and proteins from a clarified cell lysate. |
|||
Leptospira Biflexa Antigen (Strain Patoc 1) |
|||
| NAT41582-100 | The Native Antigen Company | 0.1 | EUR 391.66 |
|
Description: Inactivated Leptospira biflexa antigen (Strain Patoc 1) from broth culture. |
|||
Leptospira Biflexa Antigen (Strain Patoc 1) |
|||
| NAT41582-500 | The Native Antigen Company | 0.5 | EUR 1176.24 |
|
Description: Inactivated Leptospira biflexa antigen (Strain Patoc 1) from broth culture. |
|||
Borrelia Afzelii Antigen |
|||
| NAT41583-100 | The Native Antigen Company | 0.1 | EUR 391.66 |
|
Description: Harvested bacteria are washed and detergent solubilized to produce a cytoplasmic extract enriched with lipoproteins and outer surface proteins (OSPs). The antigen is presented in phosphate buffered saline containing 1 % n-octyl-β-D-glucopyranoside. |
|||
Borrelia Afzelii Antigen |
|||
| NAT41583-500 | The Native Antigen Company | 0.5 | EUR 1176.24 |
|
Description: Harvested bacteria are washed and detergent solubilized to produce a cytoplasmic extract enriched with lipoproteins and outer surface proteins (OSPs). The antigen is presented in phosphate buffered saline containing 1 % n-octyl-β-D-glucopyranoside. |
|||
Borrelia Garinii Antigen |
|||
| NAT41584-100 | The Native Antigen Company | 0.1 | EUR 391.66 |
|
Description: Harvested bacteria are washed and detergent solubilized to produce a cytoplasmic extract enriched with lipoproteins and outer surface proteins (OSPs). The antigen is presented in phosphate buffered saline containing 1 % n-octyl-β-D-glucopyranoside. |
|||
Borrelia Garinii Antigen |
|||
| NAT41584-500 | The Native Antigen Company | 0.5 | EUR 1176.24 |
|
Description: Harvested bacteria are washed and detergent solubilized to produce a cytoplasmic extract enriched with lipoproteins and outer surface proteins (OSPs). The antigen is presented in phosphate buffered saline containing 1 % n-octyl-β-D-glucopyranoside. |
|||
Brucella Abortus Antigen |
|||
| NAT41599-100 | The Native Antigen Company | 0.1 | EUR 391.66 |
|
Description: Brucella abortus lysate, produced by fermentation. |
|||
Brucella Abortus Antigen |
|||
| NAT41599-500 | The Native Antigen Company | 0.5 | EUR 1176.24 |
|
Description: Brucella abortus lysate, produced by fermentation. |
|||
Candida Albicans Antigen |
|||
| NAT41601-100 | The Native Antigen Company | 0.1 | EUR 391.66 |
|
Description: Candida albicans is grown on solid medium, washed, disrupted and subjected to an extraction process. The antigen consists of cytoplasmic and cell wall components. |
|||
Candida Albicans Antigen |
|||
| NAT41601-500 | The Native Antigen Company | 0.5 | EUR 1176.24 |
|
Description: Candida albicans is grown on solid medium, washed, disrupted and subjected to an extraction process. The antigen consists of cytoplasmic and cell wall components. |
|||
Canine Parvovirus Antigen |
|||
| NAT41594-100 | The Native Antigen Company | 0.1 | EUR 391.66 |
|
Description: Canine Parvovirus, produced in CRFK cells. |
|||
Human anti Human Jo-1 Antigen |
|||
| MBS315457-2mL | MyBiosource | 2mL | EUR 685 |
Human anti Human Jo-1 Antigen |
|||
| MBS315457-5x2mL | MyBiosource | 5x2mL | EUR 2910 |
Canine Coronavirus Antigen |
|||
| NAT41590-100 | The Native Antigen Company | 0.1 | EUR 391.66 |
|
Description: Canine Coronavirus produced in A-72 cells. |
|||
Feline Calicivirus Antigen |
|||
| NAT41595-100 | The Native Antigen Company | 0.1 | EUR 391.66 |
|
Description: Feline Calicivirus produced in FC 3TG cells. |
|||
Helicobacter Pylori Antigen |
|||
| NAT41603-100 | The Native Antigen Company | 0.1 | EUR 391.66 |
|
Description: Bacteria are cultured on solid medium, harvested, washed and solubilised. The antigen is partially purified by detergent extraction and centrifugation. |
|||
Helicobacter Pylori Antigen |
|||
| NAT41603-500 | The Native Antigen Company | 0.5 | EUR 1176.24 |
|
Description: Bacteria are cultured on solid medium, harvested, washed and solubilised. The antigen is partially purified by detergent extraction and centrifugation. |
|||
Campylobacter Jejuni Antigen |
|||
| NAT41600-100 | The Native Antigen Company | 0.1 | EUR 391.66 |
|
Description: Campylobacter jejuni is cultured on solid medium. This antigen is a partially purified detergent extract of the membrane fraction. The main component is an outer membrane protein, approximately 45 kDa in SDS-PAGE. |
|||
Campylobacter Jejuni Antigen |
|||
| NAT41600-500 | The Native Antigen Company | 0.5 | EUR 1176.24 |
|
Description: Campylobacter jejuni is cultured on solid medium. This antigen is a partially purified detergent extract of the membrane fraction. The main component is an outer membrane protein, approximately 45 kDa in SDS-PAGE. |
|||
Chlamydia Trachomatis Antigen |
|||
| CT022-1000 | The Native Antigen Company | 1.0 | EUR 378.9 |
|
Description: Chlamydia trachomatis antigens from clarified cell lysate. |
|||
Neisseria Gonorrhoeae Antigen |
|||
| NG01-1000 | The Native Antigen Company | 1.0 | EUR 378.9 |
|
Description: Homogenised lysate of pure bacteria. |
|||
Mycoplasma Pneumoniae Antigen |
|||
| MP901-1000 | The Native Antigen Company | 1.0 | EUR 1010.39 |
|
Description: Mycoplasma pneumoniae whole organisms that have been purified and detergent treated to enrich antigenic proteins and decrease background. |
|||
Mycoplasma Pneumoniae Antigen |
|||
| MP901-200 | The Native Antigen Company | 0.2 | EUR 270.46 |
|
Description: Mycoplasma pneumoniae whole organisms that have been purified and detergent treated to enrich antigenic proteins and decrease background. |
|||
Echovirus Antigen, Recombinant |
|||
| REC31776-100 | The Native Antigen Company | 0.1 | EUR 276.84 |
|
Description: Proprietary recombinant antigen expressed in E. coli and purified by chromatography. Individually pooled antigens shown to react with QC serum panel (multiple negative, borderline and positive sera) within defined reactivity range in Coxsackie-/Echovirus |
|||
Echovirus Antigen, Recombinant |
|||
| REC31776-500 | The Native Antigen Company | 0.5 | EUR 1043.56 |
|
Description: Proprietary recombinant antigen expressed in E. coli and purified by chromatography. Individually pooled antigens shown to react with QC serum panel (multiple negative, borderline and positive sera) within defined reactivity range in Coxsackie-/Echovirus |
|||
Trichomonas Vaginalis Antigen |
|||
| TV01-1000 | The Native Antigen Company | 1.0 | EUR 421 |
|
Description: Washed & lysed suspension of whole protozoa |
|||
Echinococcus Granulosus Antigen |
|||
| NAT41602-100 | The Native Antigen Company | 0.1 | EUR 391.66 |
|
Description: Echinococcus granulosus material is derived from bovine hydatid cyst as sterile filtered cyst fluid. |
|||
Echinococcus Granulosus Antigen |
|||
| NAT41602-500 | The Native Antigen Company | 0.5 | EUR 1176.24 |
|
Description: Echinococcus granulosus material is derived from bovine hydatid cyst as sterile filtered cyst fluid. |
|||
Enterovirus Antigen, Recombinant |
|||
| REC31772-100 | The Native Antigen Company | 0.1 | EUR 276.84 |
|
Description: Proprietary recombinant antigen expressed in E. coli and purified by chromatography. Individually pooled antigens shown to react with QC serum panel (multiple negative, borderline and positive sera) within defined reactivity range in Coxsackie-/Echovirus IgA, IgG and IgM ELISA. |
|||
Enterovirus Antigen, Recombinant |
|||
| REC31772-500 | The Native Antigen Company | 0.5 | EUR 1043.56 |
|
Description: Proprietary recombinant antigen expressed in E. coli and purified by chromatography. Individually pooled antigens shown to react with QC serum panel (multiple negative, borderline and positive sera) within defined reactivity range in Coxsackie-/Echovirus IgA, IgG and IgM ELISA. |
|||
Cytomegalovirus Purified Antigen |
|||
| CMV-HP-100 | The Native Antigen Company | 0.1 | EUR 318.94 |
|
Description: A concentrated source of human Cytomegalovirus particles purified by sucrose gradient ultracentrifugation. |
|||
Cytomegalovirus Purified Antigen |
|||
| CMV-HP-1000 | The Native Antigen Company | 1.0 | EUR 2096.06 |
|
Description: A concentrated source of human Cytomegalovirus particles purified by sucrose gradient ultracentrifugation. |
|||
Cytomegalovirus Purified Antigen |
|||
| CMV-HP-500 | The Native Antigen Company | 0.5 | EUR 1279.58 |
|
Description: A concentrated source of human Cytomegalovirus particles purified by sucrose gradient ultracentrifugation. |
|||
Yersinia pestis V antigen |
|||
| REC32028-100 | The Native Antigen Company | 0.1 | EUR 491.53 |
|
Description: Yersinia pestis V antigen (LcrV antigen, capsule protein fraction 1, type III secretion system needle tip protein). The protein is produced as an N-terminal GST fusion, with GST being cleaved by thrombin and is not present in the final product. |
|||
Yersinia pestis V antigen |
|||
| REC32028-500 | The Native Antigen Company | 0.5 | EUR 2421.37 |
|
Description: Yersinia pestis V antigen (LcrV antigen, capsule protein fraction 1, type III secretion system needle tip protein). The protein is produced as an N-terminal GST fusion, with GST being cleaved by thrombin and is not present in the final product. |
|||
Canine Herpes Virus Antigen |
|||
| NAT41592-100 | The Native Antigen Company | 0.1 | EUR 391.66 |
|
Description: Canine Herpes virus, produced in MDCK cells. |
|||
Canine Adenovirus 2 Antigen |
|||
| NAT41588-100 | The Native Antigen Company | 0.1 | EUR 391.66 |
|
Description: Canine Adenovirus Type 2, produced in A-72 cells. |
|||
OPMA04226-200UG - Jo-1 Antigen Protein |
|||
| OPMA04226-200UG | Aviva Systems Biology | 0.2MG | EUR 1399 |
OPMA04594-100UG - Jo-1 Antigen Protein |
|||
| OPMA04594-100UG | Aviva Systems Biology | 0.1MG | EUR 1499 |
Canine Distemper Virus Antigen |
|||
| NAT41591-100 | The Native Antigen Company | 0.1 | EUR 391.66 |
|
Description: Canine Distemper virus, produced in SL-29 cells. |
|||
OPEF01638-1MG - Recombinant Jo-1 Antigen |
|||
| OPEF01638-1MG | Aviva Systems Biology | 1mg | EUR 1683 |
Canine Parainfluenza Virus Antigen |
|||
| NAT41593-100 | The Native Antigen Company | 0.1 | EUR 391.66 |
|
Description: Canine Parainfluenza virus antigen, produced in MDCK cells. |
|||
Feline Panleukopenia Virus Antigen |
|||
| NAT41597-100 | The Native Antigen Company | 0.1 | EUR 391.66 |
|
Description: Feline Panleukopenia Virus (FPLV; feline parvovirus) antigen, produced in CRFK cells. |
|||
Norovirus GII.4 VP1 Antigen |
|||
| REC31620-100 | The Native Antigen Company | 0.1 | EUR 302.36 |
|
Description: Recombinant Norovirus GII.4 VP1 antigen produced in 293 human cells. |
|||
Norovirus GII.4 VP1 Antigen |
|||
| REC31620-1000 | The Native Antigen Company | 1.0 | EUR 1830.71 |
|
Description: Recombinant Norovirus GII.4 VP1 antigen produced in 293 human cells. |
|||
Norovirus GII.4 VP1 Antigen |
|||
| REC31620-500 | The Native Antigen Company | 0.5 | EUR 1066.53 |
|
Description: Recombinant Norovirus GII.4 VP1 antigen produced in 293 human cells. |
|||
Cytomegalovirus Cell Lysate Antigen |
|||
| CMV-CL-100 | The Native Antigen Company | 0.1 | EUR 223.26 |
|
Description: A clarified cell lysate containing a mix of CMV antigens from all stages of the replication life cycle. |
|||
Cytomegalovirus Cell Lysate Antigen |
|||
| CMV-CL-1000 | The Native Antigen Company | 1.0 | EUR 1422.47 |
|
Description: A clarified cell lysate containing a mix of CMV antigens from all stages of the replication life cycle. |
|||
Feline Viral Rhinotracheitis Antigen |
|||
| NAT41598-100 | The Native Antigen Company | 0.1 | EUR 391.66 |
|
Description: Feline Viral Rhinotracheitis (FVR; feline herpes virus, FHV-1) antigen, produced in CRFK cells. |
|||
Herpes Simplex Virus 2 Antigen |
|||
| HS205-1000 | The Native Antigen Company | 1.0 | EUR 1178.79 |
|
Description: HSV-2 particles from a cell lysate are purified by sucrose gradient ultracentrifugation. |
|||
Herpes Simplex Virus 2 Antigen |
|||
| HS205-200 | The Native Antigen Company | 0.2 | EUR 294.7 |
|
Description: HSV-2 particles from a cell lysate are purified by sucrose gradient ultracentrifugation. |
|||
Ross River Virus Recombinant Antigen |
|||
| REC31969-100 | The Native Antigen Company | 0.1 | EUR 757.8 |
|
Description: Recombinant Ross River virus antigen expressed in HEK293 cells as virus-like particles and purified by sucrose density gradients and precipitation. Virus-like particles were then solubilized in PBS containing 0.2% SDS to prevent aggregation of particles. The preparation is not particulate. Antigens in the preparation include Envelope proteins 1 and 2 and Nucleoprotein. |
|||
Ross River Virus Recombinant Antigen |
|||
| REC31969-500 | The Native Antigen Company | 0.5 | EUR 2844.92 |
|
Description: Recombinant Ross River virus antigen expressed in HEK293 cells as virus-like particles and purified by sucrose density gradients and precipitation. Virus-like particles were then solubilized in PBS containing 0.2% SDS to prevent aggregation of particles. The preparation is not particulate. Antigens in the preparation include Envelope proteins 1 and 2 and Nucleoprotein. |
|||
Hepatitis B Virus E Antigen (HBeAg) |
|||
| REC31677-100 | The Native Antigen Company | 0.1 | EUR 456.72 |
|
Description: Recombinant Hepititis B Virus E Protein (HBeAg). |
|||
Hepatitis B Virus E Antigen (HBeAg) |
|||
| REC31677-500 | The Native Antigen Company | 0.5 | EUR 1941.06 |
|
Description: Recombinant Hepititis B Virus E Protein (HBeAg). |
|||
Hepatitis B Virus Core Antigen (HBcAg) |
|||
| REC31689-100 | The Native Antigen Company | 0.1 | EUR 456.72 |
|
Description: Recombinant Hepititis B Virus Core Protein (HBcAg). |
|||
Hepatitis B Virus Core Antigen (HBcAg) |
|||
| REC31689-500 | The Native Antigen Company | 0.5 | EUR 1370.16 |
|
Description: Recombinant Hepititis B Virus Core Protein (HBcAg). |
|||
Hepatitis C Virus Core Antigen (HCcAg) |
|||
| REC31693-100 | The Native Antigen Company | 0.1 | EUR 484.79 |
|
Description: Recombinant Hepatitis C Virus core protein is produced in E. coli and fused with a His-tag. |
|||
Hepatitis C Virus Core Antigen (HCcAg) |
|||
| REC31693-500 | The Native Antigen Company | 0.5 | EUR 1455.64 |
|
Description: Recombinant Hepatitis C Virus core protein is produced in E. coli and fused with a His-tag. |
|||
Feline Infectious Peritonitis Virus Antigen |
|||
| NAT41596-100 | The Native Antigen Company | 0.1 | EUR 391.66 |
|
Description: Feline Infectious Peritonitis virus (FIPV; feline coronavirus) antigen, produced in CRFK cells. |
|||
Herpes Simplex Virus 2 Lysate Antigen |
|||
| HS204-1000 | The Native Antigen Company | 1.0 | EUR 270.46 |
|
Description: A high concentration of HSV-2 particles and proteins from a clarified cell lysate. |
|||
Legionella pneumophila antigen (native extract) |
|||
| NAT41580-100 | The Native Antigen Company | 0.1 | EUR 391.66 |
|
Description: Inactivated Legionella pneumophila antigen from culture. |
|||
Streptococcus Pneumoniae Antigen, Native Extract |
|||
| NAT41604-100 | The Native Antigen Company | 0.1 | EUR 391.66 |
|
Description: Inactivated Streptococcus pneumoniae antigen from culture. |
|||
Jo-1 Antigen human polyclonal antibody, Purified |
|||
| BP2040 | Origene Technologies GmbH | 2 ml | Ask for price |
Mouse Anti-Hepatitis B Surface Antigen Antibody (1834) |
|||
| MAB12230-100 | The Native Antigen Company | 0.1 | EUR 275.56 |
|
Description: Mouse monoclonal antibody specific for Hepatitis B virus surface antigen (1834). |
|||
Mouse Anti-Hepatitis B Surface Antigen Antibody (1837) |
|||
| MAB12231-100 | The Native Antigen Company | 0.1 | EUR 275.56 |
|
Description: Mouse monoclonal antibody specific for Hepatitis B virus surface antigen (1837) |
|||
Mouse Anti-Hepatitis B Surface Antigen Antibody (1838) |
|||
| MAB12232-100 | The Native Antigen Company | 0.1 | EUR 275.56 |
|
Description: Mouse monoclonal antibody specific for Hepatitis B virus surface antigen (1838) |
|||
Mouse Anti-Hepatitis B Virus E Antigen Antibody (1892) |
|||
| MAB12226-100 | The Native Antigen Company | 0.1 | EUR 275.56 |
|
Description: Mouse monoclonal antibody specific for Hepatitis B virus e antigen (1892) |
|||
Mouse Anti-Hepatitis B Virus E Antigen Antibody (1893) |
|||
| MAB12227-100 | The Native Antigen Company | 0.1 | EUR 275.56 |
|
Description: Mouse monoclonal antibody specific for Hepatitis B virus e antigen (1893) |
|||
Mouse Anti-Hepatitis B Virus E Antigen Antibody (1894) |
|||
| MAB12228-100 | The Native Antigen Company | 0.1 | EUR 275.56 |
|
Description: Mouse monoclonal antibody specific for Hepatitis B virus e antigen (1894) |
|||
Mouse Anti-Hepatitis B Virus E Antigen Antibody (M132) |
|||
| MAB12298-100 | The Native Antigen Company | 0.1 | EUR 276.84 |
|
Description: Mouse monoclonal antibody specific for Hepatitis B virus e antigen (M132) |
|||
Mouse Anti-Hepatitis B Virus E Antigen Antibody (M132) |
|||
| MAB12298-500 | The Native Antigen Company | 0.5 | EUR 695.29 |
|
Description: Mouse monoclonal antibody specific for Hepatitis B virus e antigen (M132) |
|||
Mouse Anti-Hepatitis B Virus E Antigen Antibody (M133) |
|||
| MAB12299-100 | The Native Antigen Company | 0.1 | EUR 276.84 |
|
Description: Mouse monoclonal antibody specific for Hepatitis B virus e antigen (M133) |
|||
Mouse Anti-Hepatitis B Virus E Antigen Antibody (M133) |
|||
| MAB12299-500 | The Native Antigen Company | 0.5 | EUR 695.29 |
|
Description: Mouse monoclonal antibody specific for Hepatitis B virus e antigen (M133) |
|||
Yersinia pestis chain B F1 capsule antigen, C-terminal His-tag |
|||
| REC32027-100 | The Native Antigen Company | 0.1 | EUR 491.53 |
|
Description: Yersinia pestis chain B F1 capsule antigen (Antig_Caf1) |
|||
Yersinia pestis chain B F1 capsule antigen, C-terminal His-tag |
|||
| REC32027-500 | The Native Antigen Company | 0.5 | EUR 2421.37 |
|
Description: Yersinia pestis chain B F1 capsule antigen (Antig_Caf1) |
|||
MAGE-1 (Melanoma-associated Antigen 1, MAGE-1 Antigen, Cancer/testis Antigen, CTA) (AP) |
|||
| MBS6122321-01mL | MyBiosource | 0.1(mL | EUR 935 |
MAGE-1 (Melanoma-associated Antigen 1, MAGE-1 Antigen, Cancer/testis Antigen, CTA) (AP) |
|||
| MBS6122321-5x01mL | MyBiosource | 5x0.1mL | EUR 4050 |
MAGE-1 (Melanoma-associated Antigen 1, MAGE-1 Antigen, Cancer/testis Antigen, CTA) (APC) |
|||
| MBS6122322-01mL | MyBiosource | 0.1(mL | EUR 935 |
MAGE-1 (Melanoma-associated Antigen 1, MAGE-1 Antigen, Cancer/testis Antigen, CTA) (APC) |
|||
| MBS6122322-5x01mL | MyBiosource | 5x0.1mL | EUR 4050 |
MAGE-1 (Melanoma-associated Antigen 1, MAGE-1 Antigen, Cancer/testis Antigen, CTA) (HRP) |
|||
| MBS6122325-01mL | MyBiosource | 0.1(mL | EUR 935 |
MAGE-1 (Melanoma-associated Antigen 1, MAGE-1 Antigen, Cancer/testis Antigen, CTA) (HRP) |
|||
| MBS6122325-5x01mL | MyBiosource | 5x0.1mL | EUR 4050 |
MAGE-1 (Melanoma-associated Antigen 1, MAGE-1 Antigen, Cancer/testis Antigen, CTA) (PE) |
|||
| MBS6122326-01mL | MyBiosource | 0.1(mL | EUR 935 |
MAGE-1 (Melanoma-associated Antigen 1, MAGE-1 Antigen, Cancer/testis Antigen, CTA) (PE) |
|||
| MBS6122326-5x01mL | MyBiosource | 5x0.1mL | EUR 4050 |
MAGE-1 (Melanoma-associated Antigen 1, MAGE-1 Antigen, Cancer/testis Antigen, CTA) (FITC) |
|||
| MBS6122324-01mL | MyBiosource | 0.1(mL | EUR 935 |
MAGE-1 (Melanoma-associated Antigen 1, MAGE-1 Antigen, Cancer/testis Antigen, CTA) (FITC) |
|||
| MBS6122324-5x01mL | MyBiosource | 5x0.1mL | EUR 4050 |
MAGE-1 (Melanoma-associated Antigen 1, MAGE-1 Antigen, Cancer/testis Antigen, CTA) (Biotin) |
|||
| MBS6122323-01mL | MyBiosource | 0.1(mL | EUR 935 |
MAGE-1 (Melanoma-associated Antigen 1, MAGE-1 Antigen, Cancer/testis Antigen, CTA) (Biotin) |
|||
| MBS6122323-5x01mL | MyBiosource | 5x0.1mL | EUR 4050 |
GAGE1 (G Antigen 1, GAGE-1, Antigen MZ2-F, Cancer/Testis Antigen 4.1, CT4.1) |
|||
| MBS6009107-005mg | MyBiosource | 0.05(mg | EUR 630 |
GAGE1 (G Antigen 1, GAGE-1, Antigen MZ2-F, Cancer/Testis Antigen 4.1, CT4.1) |
|||
| MBS6009107-5x005mg | MyBiosource | 5x0.05mg | EUR 2680 |
MAGE-1 (Melanoma-associated Antigen 1, MAGE-1 Antigen, Cancer/testis Antigen, CTA) (MaxLight 490) |
|||
| MBS6204325-01mL | MyBiosource | 0.1(mL | EUR 935 |
MAGE-1 (Melanoma-associated Antigen 1, MAGE-1 Antigen, Cancer/testis Antigen, CTA) (MaxLight 490) |
|||
| MBS6204325-5x01mL | MyBiosource | 5x0.1mL | EUR 4050 |
MAGE-1 (Melanoma-associated Antigen 1, MAGE-1 Antigen, Cancer/testis Antigen, CTA) (MaxLight 405) |
|||
| MBS6193650-01mL | MyBiosource | 0.1(mL | EUR 935 |
MAGE-1 (Melanoma-associated Antigen 1, MAGE-1 Antigen, Cancer/testis Antigen, CTA) (MaxLight 405) |
|||
| MBS6193650-5x01mL | MyBiosource | 5x0.1mL | EUR 4050 |
MAGE-1 (Melanoma-associated Antigen 1, MAGE-1 Antigen, Cancer/testis Antigen, CTA) (MaxLight 750) |
|||
| MBS6236350-01mL | MyBiosource | 0.1(mL | EUR 935 |
MAGE-1 (Melanoma-associated Antigen 1, MAGE-1 Antigen, Cancer/testis Antigen, CTA) (MaxLight 750) |
|||
| MBS6236350-5x01mL | MyBiosource | 5x0.1mL | EUR 4050 |
MAGE-1 (Melanoma-associated Antigen 1, MAGE-1 Antigen, Cancer/testis Antigen, CTA) (MaxLight 650) |
|||
| MBS6225675-01mL | MyBiosource | 0.1(mL | EUR 935 |
MAGE-1 (Melanoma-associated Antigen 1, MAGE-1 Antigen, Cancer/testis Antigen, CTA) (MaxLight 650) |
|||
| MBS6225675-5x01mL | MyBiosource | 5x0.1mL | EUR 4050 |
MAGE-1 (Melanoma-associated Antigen 1, MAGE-1 Antigen, Cancer/testis Antigen, CTA) (MaxLight 550) |
|||
| MBS6215000-01mL | MyBiosource | 0.1(mL | EUR 935 |
MAGE-1 (Melanoma-associated Antigen 1, MAGE-1 Antigen, Cancer/testis Antigen, CTA) (MaxLight 550) |
|||
| MBS6215000-5x01mL | MyBiosource | 5x0.1mL | EUR 4050 |
HSV-1 Antigen |
|||
| E4A10F07 | EnoGene | 50ug | EUR 255 |
|
Description: Available in various conjugation types. |
|||
MAGEA1 (Melanoma-associated Antigen 1, MAGE-1 Antigen, Antigen MZ2-E, Cancer/Testis Antigen 1.1, CT1.1, MAGE1, MGC9326) APC |
|||
| MBS6137480-01mL | MyBiosource | 0.1(mL | EUR 875 |
MAGEA1 (Melanoma-associated Antigen 1, MAGE-1 Antigen, Antigen MZ2-E, Cancer/Testis Antigen 1.1, CT1.1, MAGE1, MGC9326) APC |
|||
| MBS6137480-5x01mL | MyBiosource | 5x0.1mL | EUR 3800 |
MAGEA1 (Melanoma-associated Antigen 1, MAGE-1 Antigen, Antigen MZ2-E, Cancer/Testis Antigen 1.1, CT1.1, MAGE1, MGC9326) (AP) |
|||
| MBS6132177-01mL | MyBiosource | 0.1(mL | EUR 875 |
MAGEA1 (Melanoma-associated Antigen 1, MAGE-1 Antigen, Antigen MZ2-E, Cancer/Testis Antigen 1.1, CT1.1, MAGE1, MGC9326) (AP) |
|||
| MBS6132177-5x01mL | MyBiosource | 5x0.1mL | EUR 3800 |
MAGEA1 (Melanoma-associated Antigen 1, MAGE-1 Antigen, Antigen MZ2-E, Cancer/Testis Antigen 1.1, CT1.1, MAGE1, MGC9326) (AP) |
|||
| MBS6401109-01mL | MyBiosource | 0.1mL | EUR 1040 |
MAGEA1 (Melanoma-associated Antigen 1, MAGE-1 Antigen, Antigen MZ2-E, Cancer/Testis Antigen 1.1, CT1.1, MAGE1, MGC9326) (AP) |
|||
| MBS6401109-5x01mL | MyBiosource | 5x0.1mL | EUR 4540 |
MAGEA1 (Melanoma-associated Antigen 1, MAGE-1 Antigen, Antigen MZ2-E, Cancer/Testis Antigen 1.1, CT1.1, MAGE1, MGC9326) (APC) |
|||
| MBS6401110-01mL | MyBiosource | 0.1mL | EUR 1040 |
MAGEA1 (Melanoma-associated Antigen 1, MAGE-1 Antigen, Antigen MZ2-E, Cancer/Testis Antigen 1.1, CT1.1, MAGE1, MGC9326) (APC) |
|||
| MBS6401110-5x01mL | MyBiosource | 5x0.1mL | EUR 4540 |
MAGEA1 (Melanoma-associated Antigen 1, MAGE-1 Antigen, Antigen MZ2-E, Cancer/Testis Antigen 1.1, CT1.1, MAGE1, MGC9326) (HRP) |
|||
| MBS6401113-01mL | MyBiosource | 0.1mL | EUR 1040 |
MAGEA1 (Melanoma-associated Antigen 1, MAGE-1 Antigen, Antigen MZ2-E, Cancer/Testis Antigen 1.1, CT1.1, MAGE1, MGC9326) (HRP) |
|||
| MBS6401113-5x01mL | MyBiosource | 5x0.1mL | EUR 4540 |
MAGEA1 (Melanoma-associated Antigen 1, MAGE-1 Antigen, Antigen MZ2-E, Cancer/Testis Antigen 1.1, CT1.1, MAGE1, MGC9326) (PE) |
|||
| MBS6401119-01mL | MyBiosource | 0.1mL | EUR 1040 |
MAGEA1 (Melanoma-associated Antigen 1, MAGE-1 Antigen, Antigen MZ2-E, Cancer/Testis Antigen 1.1, CT1.1, MAGE1, MGC9326) (PE) |
|||
| MBS6401119-5x01mL | MyBiosource | 5x0.1mL | EUR 4540 |
MAGEA1, ID (Melanoma-associated Antigen 1, MAGE-1 Antigen, Antigen MZ2-E, Cancer/Testis Antigen 1.1, CT1.1, MAGE1, MAGE1A) |
|||
| MBS629135-02mL | MyBiosource | 0.2mL | EUR 695 |
MAGEA1, ID (Melanoma-associated Antigen 1, MAGE-1 Antigen, Antigen MZ2-E, Cancer/Testis Antigen 1.1, CT1.1, MAGE1, MAGE1A) |
|||
| MBS629135-5x02mL | MyBiosource | 5x0.2mL | EUR 2975 |
MAGEA1 (Melanoma-associated Antigen 1, MAGE-1 Antigen, Antigen MZ2-E, Cancer/Testis Antigen 1.1, CT1.1, MAGE1, MGC9326) (HRP) |
|||
| MBS6153389-01mL | MyBiosource | 0.1(mL | EUR 875 |
MAGEA1 (Melanoma-associated Antigen 1, MAGE-1 Antigen, Antigen MZ2-E, Cancer/Testis Antigen 1.1, CT1.1, MAGE1, MGC9326) (HRP) |
|||
| MBS6153389-5x01mL | MyBiosource | 5x0.1mL | EUR 3800 |
MAGEA1 (Melanoma-associated Antigen 1, MAGE-1 Antigen, Antigen MZ2-E, Cancer/Testis Antigen 1.1, CT1.1, MAGE1, MGC9326) (PE) |
|||
| MBS6158692-01mL | MyBiosource | 0.1(mL | EUR 875 |
MAGEA1 (Melanoma-associated Antigen 1, MAGE-1 Antigen, Antigen MZ2-E, Cancer/Testis Antigen 1.1, CT1.1, MAGE1, MGC9326) (PE) |
|||
| MBS6158692-5x01mL | MyBiosource | 5x0.1mL | EUR 3800 |
MAGEA1 (Melanoma-associated Antigen 1, MAGE-1 Antigen, Antigen MZ2-E, Cancer/Testis Antigen 1.1, CT1.1, MAGE1, MGC9326) (Biotin) |
|||
| MBS6142783-01mL | MyBiosource | 0.1(mL | EUR 875 |
MAGEA1 (Melanoma-associated Antigen 1, MAGE-1 Antigen, Antigen MZ2-E, Cancer/Testis Antigen 1.1, CT1.1, MAGE1, MGC9326) (Biotin) |
|||
| MBS6142783-5x01mL | MyBiosource | 5x0.1mL | EUR 3800 |
MAGEA1 (Melanoma-associated Antigen 1, MAGE-1 Antigen, Antigen MZ2-E, Cancer/Testis Antigen 1.1, CT1.1, MAGE1, MGC9326) (FITC) |
|||
| MBS6148086-01mL | MyBiosource | 0.1(mL | EUR 875 |
MAGEA1 (Melanoma-associated Antigen 1, MAGE-1 Antigen, Antigen MZ2-E, Cancer/Testis Antigen 1.1, CT1.1, MAGE1, MGC9326) (FITC) |
|||
| MBS6148086-5x01mL | MyBiosource | 5x0.1mL | EUR 3800 |
MAGEA1 (Melanoma-associated Antigen 1, MAGE-1 Antigen, Antigen MZ2-E, Cancer/Testis Antigen 1.1, CT1.1, MAGE1, MGC9326) (Biotin) |
|||
| MBS6401111-01mL | MyBiosource | 0.1mL | EUR 1040 |
MAGEA1 (Melanoma-associated Antigen 1, MAGE-1 Antigen, Antigen MZ2-E, Cancer/Testis Antigen 1.1, CT1.1, MAGE1, MGC9326) (Biotin) |
|||
| MBS6401111-5x01mL | MyBiosource | 5x0.1mL | EUR 4540 |
MAGEA1 (Melanoma-associated Antigen 1, MAGE-1 Antigen, Antigen MZ2-E, Cancer/Testis Antigen 1.1, CT1.1, MAGE1, MGC9326) (FITC) |
|||
| MBS6401112-01mL | MyBiosource | 0.1mL | EUR 1040 |
MAGEA1 (Melanoma-associated Antigen 1, MAGE-1 Antigen, Antigen MZ2-E, Cancer/Testis Antigen 1.1, CT1.1, MAGE1, MGC9326) (FITC) |
|||
| MBS6401112-5x01mL | MyBiosource | 5x0.1mL | EUR 4540 |
Cancer Antigen 15-3 MUC 1 Antigen (Human Milk) |
|||
| VAng-Cr3871-10kU | Creative Biolabs | 10 kU | EUR 505.2 |
|
Description: Cancer Antigen 15-3 MUC 1 Antigen, Host/Source: Human Milk. The purity is detected by salt extraction and delipidization following high speed centrifugation. It is tested negative for HBsAg, antibodies to HCV and HIV 1/2. |
|||
CAMPATH-1 antigen |
|||
| AP81579 | SAB | 1mg | EUR 2640 |
CAMPATH-1 antigen |
|||
| AP81656 | SAB | 1mg | EUR 2640 |
CAMPATH-1 antigen |
|||
| AP81694 | SAB | 1mg | EUR 2640 |
CAMPATH-1 antigen |
|||
| AP81715 | SAB | 1mg | EUR 2640 |
MAGEA1, ID (Melanoma-associated Antigen 1, MAGE-1 Antigen, Antigen MZ2-E, Cancer/Testis Antigen 1.1, CT1.1, MAGE1, MAGE1A) (AP) |
|||
| MBS6486187-02mL | MyBiosource | 0.2mL | EUR 980 |
MAGEA1, ID (Melanoma-associated Antigen 1, MAGE-1 Antigen, Antigen MZ2-E, Cancer/Testis Antigen 1.1, CT1.1, MAGE1, MAGE1A) (AP) |
|||
| MBS6486187-5x02mL | MyBiosource | 5x0.2mL | EUR 4250 |
A Gene Expression Signature for Predicting Response to Neoadjuvant Chemoradiotherapy in Pancreatic Ductal Adenocarcinoma
In patients with pancreatic ductal adenocarcinoma (PDAC), optimal treatment selection, including multimodality regimens such as neoadjuvant chemoradiotherapy (NACRT) can be clinically transformative. Unfortunately, currently no predictive biomarkers are available that can guide the use of NACRT in PDAC patients. Accordingly, herein we developed a novel gene signature that can pre-operatively predict NACRT-sensitivity in PDAC patients.
Herein, we evaluated the performance of a 10-gene panel in 749 PDAC cases, which included two public datasets (TCGA, ICGC; n = 276), and three clinical specimen cohorts (n = 417), and a pre-NACRT endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) biopsy cohort (n = 56). The potential predictive performance of this signature was evaluated and compared to CA-19-9 levels and key clinicopathological factors. We first evaluated the prognostic potential of a 10-gene panel which significantly predicted overall survival in both public datasets (P < 0.01, P < 0.01), and two in-house patient cohorts (P < 0.01, P = 0.04). In the pre-NACRT EUS-FNA cohort, we established a radio-sensitivity gene panel (RSGP) which yielded was highly robust (AUC = 0.91; 95% CI; 0.81-0.97) for predicting response to gemcitabine-based NACRT.
Multivariate logistic regression analysis revealed that RSGP was an indepeave validated and developed a novel gene signature that is ndent predictor for response to NACRT (OR = 2.70, 95% CI = 1.25-5.85), and this response-prediction was even more robust when CA-19-9 levels were included into the model. In conclusion, we hhighly robust in predicting response to NACRT, even in pre-operative settings, highlighting its clinical significance for optimizing and personalizing treatment strategies in PDAC patients. This article is protected by copyright. All rights reserved.
Liraglutide treatment improves endothelial function in the Ldlr-/- mouse model of atherosclerosis, and affects genes involved in vascular remodelling and inflammation
Recent clinical intervention studies have shown that the GLP1 analogue liraglutide lowers cardiovascular risk, but the underlying mechanism has not yet been fully elucidated. This study investigated effects of liraglutide on endothelial function in the Ldlr-/- mouse model. Mice (n=12/group) were fed western diet or chow for 12 weeks followed by four weeks of treatment with liraglutide (1mg/kg/day) or vehicle subcutaneously.
Weight loss, blood lipid content, plaque burden, vasomotor function of the aorta, and gene expression pattern in aorta and brachiocephalic artery were monitored. Liraglutide treatment significantly induced weight loss (p<0.0001), decreased blood triglycerides (p<0.0001), and total cholesterol (p<0.0001) in western diet-fed mice but did not decrease plaque burden. Liraglutide also improved endothelium-mediated dilation of the distal thoracis aorta (p= 0.0067), but it did not affect phenylephrine or sodium nitroprusside responses.
Fluidigm analyses of 96 genes showed significantly altered expression of seven genes related to inflammation, vascular smooth muscle cells and extracellular matrix composition in liraglutide-treated animals. We conclude that treatment with liraglutide decreased endothelial dysfunction, and that this could be linked to decreased inflammation or regulation of vascular remodelling.
Alleles in metabolic and oxygen-sensing genes are associated with antagonistic pleiotropic effects on life history traits and population fitness in an ecological model insect
Genes with opposing effects on fitness at different life stages are the mechanistic basis for evolutionary theories of aging and life history. Examples come from studies of mutations in model organisms, but there is little knowledge of genetic bases of life history tradeoffs in natural populations. Here we test the hypothesis that alleles affecting oxygen sensing in Glanville fritillary butterflies have opposing effects on larval versus adult fitness-related traits. Intermediate-frequency alleles in Succinate dehydrogenase d, and to a lesser extent Hypoxia inducible factor 1α, are associated in larvae with variation in metabolic rate and activation of the hypoxia inducible factor (HIF) pathway, which affects tracheal development and delivery of oxygen to adult flight muscles.
A dominant Sdhd allele is likely to cause antagonistic pleiotropy for fitness through its opposing effects on larval metabolic and growth rate versus adult flight and dispersal, and may have additional effects arising from sensitivity to low-iron host plants. Prior results in Glanville fritillaries indicate that fitness of alleles in Sdhd and another antagonistically pleiotropic metabolic gene, Phosphoglucose isomerase, depend strongly on the size and distribution of host plant patches. Hence, these intermediate-frequency alleles are involved in eco-evolutionary dynamics involving life history tradeoffs. This article is protected by copyright. All rights reserved.
VZV / HHV-3 Ellen strain, Glycoprotein E + I mouse monoclonal antibody, clone SG1, Azide Free |
|||
| AM33128PU-N | Origene Technologies GmbH | 0.5 mg | Ask for price |
VZV / HHV-3 Ellen strain, Glycoprotein IV (GI) mouse monoclonal antibody, clone SG4, Azide Free |
|||
| BM3013 | Origene Technologies GmbH | 0.5 mg | Ask for price |
VZV / HHV-3 Ellen strain, Glycoprotein H (GPIII) mouse monoclonal antibody, clone SG3, Azide Free |
|||
| BM3012 | Origene Technologies GmbH | 0.5 mg | Ask for price |
Varicella Zoster Virus (VZV) Glycoprotein Antigen |
|||
| PR-BA104VSG-L | Jena Bioscience GmbH | 1mg | EUR 2194.6 |
|
Description: native, HEL-299 cell culture |
|||
Varicella Zoster Virus (VZV) Glycoprotein Antigen |
|||
| PR-BA104VSG-S | Jena Bioscience GmbH | 250µg | EUR 732.6 |
|
Description: native, HEL-299 cell culture |
|||
OPMA04419-1MG - VZV glycoprotein Antigen Protein |
|||
| OPMA04419-1MG | Aviva Systems Biology | 1mg | EUR 3599 |
Varicella Zoster Virus, Glycoprotein E, Ellen Strain, Recombinant (VZVgE) |
|||
| MBS636749-1mg | MyBiosource | 1mg | EUR 1845 |
Varicella Zoster Virus, Glycoprotein E, Ellen Strain, Recombinant (VZVgE) |
|||
| MBS636749-5x1mg | MyBiosource | 5x1mg | EUR 8155 |
Varicella Zoster Virus (VZV) Envelope Glycoprotein E Control Antigen |
|||
| BA104R02 | Genovis AB | 1 mg | EUR 953 |
VZV Glycoprotein |
|||
| DAG3110 | Creative Diagnostics | 1 mg | EUR 988.8 |
Recombinant Varicella-Zoster Virus Glycoprotein E (GE), (Ellen Strain), GST-tagged |
|||
| DAG518 | Creative Diagnostics | 1mg | EUR 1537.2 |
Chikungunya Glycoprotein E2 Antigen |
|||
| BA148R1 | Genovis AB | 1mg | EUR 1348 |
Chikungunya Glycoprotein E1 Antigen |
|||
| BA148R2 | Genovis AB | 1mg | EUR 1348 |
Alpha 1 Acid Glycoprotein Antigen >=95% |
|||
| MBS568622-4mg | MyBiosource | 4mg | EUR 545 |
Alpha 1 Acid Glycoprotein Antigen >=95% |
|||
| MBS568622-5x4mg | MyBiosource | 5x4mg | EUR 2180 |
Recombinant VZV Glycoprotein E (gE), Flag Tag |
|||
| P2006-.1 | ApexBio | 100ug | EUR 203.2 |
|
Description: Peptides & Proteins|Recombinant Proteins |
|||
Recombinant VZV Glycoprotein E (gE), Flag Tag |
|||
| P2006-1 | ApexBio | 1mg | EUR 1440 |
|
Description: Peptides & Proteins|Recombinant Proteins |
|||
Mouse Anti-CMV Glycoprotein B Antibody |
|||
| MAB12120-200 | The Native Antigen Company | 0.2 | EUR 884.52 |
|
Description: Mouse monoclonal antibody specific for CMV glycoprotein B (clone HCMV37) |
|||
Antigen-presenting glycoprotein CD1d |
|||
| MBS7042397-002mg | MyBiosource | 0.02mg | EUR 1630 |
Antigen-presenting glycoprotein CD1d |
|||
| MBS7042397-01mg | MyBiosource | 0.1mg | EUR 2585 |
Antigen-presenting glycoprotein CD1d |
|||
| MBS7042397-5x01mg | MyBiosource | 5x0.1mg | EUR 11595 |
Mouse Anti Rubella virus Glycoprotein E1 (1712) |
|||
| MAB12263-100 | The Native Antigen Company | 0.1 | EUR 275.56 |
|
Description: Mouse monoclonal antibody specific for Rubella virus, glycoprotein E1 (1712). |
|||
Mouse Anti Rubella virus Glycoprotein E1 (1714) |
|||
| MAB12264-100 | The Native Antigen Company | 0.1 | EUR 275.56 |
|
Description: Mouse monoclonal antibody specific for Rubella virus, glycoprotein E1 (1714). |
|||
Mouse Anti Rubella virus Glycoprotein E1 (1715) |
|||
| MAB12265-100 | The Native Antigen Company | 0.1 | EUR 275.56 |
|
Description: Mouse monoclonal antibody specific for Rubella virus, glycoprotein E1 (1715) |
|||
Mouse Anti Rubella virus Glycoprotein E2 (1717) |
|||
| MAB12266-100 | The Native Antigen Company | 0.1 | EUR 275.56 |
|
Description: Mouse monoclonal antibody specific for Rubella virus, glycoprotein E2 (1717) |
|||
Varicella-Zoster Virus Glycoprotein Antigen |
|||
| BA104VSG | Genovis AB | 1mg | EUR 1382 |
Chikungunya Glycoprotein E1 (A226V) Antigen |
|||
| BA148R3 | Genovis AB | 1mg | EUR 1348 |
Mouse Anti-Cytomegalovirus Glycoprotein H (gH) (0861) |
|||
| MAB12194-100 | The Native Antigen Company | 0.1 | EUR 275.56 |
|
Description: Mouse monoclonal antibody specific for CMV glycoprotein H (clone 0861) |
|||
membrane glycoprotein E (VZV) Antibody HRP Conjugated |
|||
| MBS9461148-01mL | MyBiosource | 0.1mL | EUR 595 |
membrane glycoprotein E (VZV) Antibody HRP Conjugated |
|||
| MBS9461148-5x01mL | MyBiosource | 5x0.1mL | EUR 2525 |
Oncofetal Antigen 5T4 (TPBG, Trophoblast Glycoprotein, 5T4 Oncofetal antigen, 5T4 Oncofetal Trophoblast Glycoprotein, M6P1) |
|||
| MBS6001947-01mg | MyBiosource | 0.1(mg | EUR 630 |
Oncofetal Antigen 5T4 (TPBG, Trophoblast Glycoprotein, 5T4 Oncofetal antigen, 5T4 Oncofetal Trophoblast Glycoprotein, M6P1) |
|||
| MBS6001947-5x01mg | MyBiosource | 5x0.1mg | EUR 2680 |
Oncofetal Antigen 5T4 (TPBG, Trophoblast Glycoprotein, 5T4 Oncofetal antigen, 5T4 Oncofetal Trophoblast Glycoprotein, M6P1) |
|||
| MBS606018-01mg | MyBiosource | 0.1mg | EUR 905 |
Oncofetal Antigen 5T4 (TPBG, Trophoblast Glycoprotein, 5T4 Oncofetal antigen, 5T4 Oncofetal Trophoblast Glycoprotein, M6P1) |
|||
| MBS606018-5x01mg | MyBiosource | 5x0.1mg | EUR 3925 |
Oncofetal Antigen 5T4 (TPBG, Trophoblast Glycoprotein, 5T4 Oncofetal antigen, 5T4 Oncofetal Trophoblast Glycoprotein, M6P1) |
|||
| MBS645334-005mg | MyBiosource | 0.05mg | EUR 630 |
Oncofetal Antigen 5T4 (TPBG, Trophoblast Glycoprotein, 5T4 Oncofetal antigen, 5T4 Oncofetal Trophoblast Glycoprotein, M6P1) |
|||
| MBS645334-5x005mg | MyBiosource | 5x0.05mg | EUR 2680 |
Oncofetal Antigen 5T4 (TPBG, Trophoblast Glycoprotein, 5T4 Oncofetal antigen, 5T4 Oncofetal Trophoblast Glycoprotein, M6P1) |
|||
| MBS622542-01mg | MyBiosource | 0.1mg | EUR 920 |
Oncofetal Antigen 5T4 (TPBG, Trophoblast Glycoprotein, 5T4 Oncofetal antigen, 5T4 Oncofetal Trophoblast Glycoprotein, M6P1) |
|||
| MBS622542-5x01mg | MyBiosource | 5x0.1mg | EUR 3980 |
Oncofetal Antigen 5T4 (TPBG, Trophoblast Glycoprotein, 5T4 Oncofetal antigen, 5T4 Oncofetal Trophoblast Glycoprotein, M6P1) |
|||
| MBS6008687-01mg | MyBiosource | 0.1(mg | EUR 665 |
Oncofetal Antigen 5T4 (TPBG, Trophoblast Glycoprotein, 5T4 Oncofetal antigen, 5T4 Oncofetal Trophoblast Glycoprotein, M6P1) |
|||
| MBS6008687-5x01mg | MyBiosource | 5x0.1mg | EUR 2850 |
Herpes simplex Virus 1 Glycoprotein G Antigen |
|||
| BA1051RVS-G | Genovis AB | 1mg | EUR 1138 |
Herpes simplex Virus 2 Glycoprotein G Antigen |
|||
| BA1052RVS-G | Genovis AB | 1mg | EUR 1138 |
Mouse Anti Nipah Virus Glycoprotein G (AE6) |
|||
| MAB12306-100 | The Native Antigen Company | 0.1 | EUR 275.56 |
|
Description: Mouse monoclonal antibody specific for Nipah virus gG |
|||
Mouse Anti Nipah Virus Glycoprotein G (AE6) |
|||
| MAB12306-500 | The Native Antigen Company | 0.5 | EUR 691.46 |
|
Description: Mouse monoclonal antibody specific for Nipah virus gG |
|||
Mouse Anti Nipah Virus Glycoprotein G (JB3) |
|||
| MAB12308-100 | The Native Antigen Company | 0.1 | EUR 275.56 |
|
Description: Mouse monoclonal antibody specific for Nipah virus gG |
|||
Mouse Anti Nipah Virus Glycoprotein G (JB3) |
|||
| MAB12308-500 | The Native Antigen Company | 0.5 | EUR 691.46 |
|
Description: Mouse monoclonal antibody specific for Nipah virus gG |
|||
Mouse Anti-Cytomegalovirus Glycoprotein B Antibody (0826) |
|||
| MAB12191-100 | The Native Antigen Company | 0.1 | EUR 275.56 |
|
Description: Mouse monoclonal antibody specific for CMV glycoprotein B (clone 0826) |
|||
Mouse Anti-Cytomegalovirus Glycoprotein B Antibody (0811) |
|||
| MAB12192-100 | The Native Antigen Company | 0.1 | EUR 275.56 |
|
Description: Mouse monoclonal antibody specific for CMV glycoprotein B (clone 0811) |
|||
Mouse Anti Nipah Virus Glycoprotein G (CF12) |
|||
| MAB12304-100 | The Native Antigen Company | 0.1 | EUR 275.56 |
|
Description: Mouse monoclonal antibody specific for Nipah virus gG |
|||
Mouse Anti Nipah Virus Glycoprotein G (CF12) |
|||
| MAB12304-500 | The Native Antigen Company | 0.5 | EUR 691.46 |
|
Description: Mouse monoclonal antibody specific for Nipah virus gG |
|||
Mouse Anti Nipah Virus Glycoprotein G (IG10) |
|||
| MAB12305-100 | The Native Antigen Company | 0.1 | EUR 275.56 |
|
Description: Mouse monoclonal antibody specific for Nipah virus gG |
|||
Mouse Anti Nipah Virus Glycoprotein G (IG10) |
|||
| MAB12305-500 | The Native Antigen Company | 0.5 | EUR 691.46 |
|
Description: Mouse monoclonal antibody specific for Nipah virus gG |
|||
Mouse Anti Nipah Virus Glycoprotein F (CG11) |
|||
| MAB12307-100 | The Native Antigen Company | 0.1 | EUR 275.56 |
|
Description: Mouse monoclonal antibody specific for Nipah virus gF |
|||
Mouse Anti Nipah Virus Glycoprotein F (CG11) |
|||
| MAB12307-500 | The Native Antigen Company | 0.5 | EUR 691.46 |
|
Description: Mouse monoclonal antibody specific for Nipah virus gF |
|||
Oncofetal Antigen 5T4 (TPBG, Trophoblast Glycoprotein, 5T4 Oncofetal antigen, 5T4 Oncofetal Trophoblast Glycoprotein, M6P1) APC |
|||
| MBS6138012-01mL | MyBiosource | 0.1(mL | EUR 875 |
Oncofetal Antigen 5T4 (TPBG, Trophoblast Glycoprotein, 5T4 Oncofetal antigen, 5T4 Oncofetal Trophoblast Glycoprotein, M6P1) APC |
|||
| MBS6138012-5x01mL | MyBiosource | 5x0.1mL | EUR 3800 |
Oncofetal Antigen 5T4 (TPBG, Trophoblast Glycoprotein, 5T4 Oncofetal antigen, 5T4 Oncofetal Trophoblast Glycoprotein, M6P1) (AP) |
|||
| MBS6132709-01mL | MyBiosource | 0.1(mL | EUR 875 |
Oncofetal Antigen 5T4 (TPBG, Trophoblast Glycoprotein, 5T4 Oncofetal antigen, 5T4 Oncofetal Trophoblast Glycoprotein, M6P1) (AP) |
|||
| MBS6132709-5x01mL | MyBiosource | 5x0.1mL | EUR 3800 |
Oncofetal Antigen 5T4 (TPBG, Trophoblast Glycoprotein, 5T4 Oncofetal antigen, 5T4 Oncofetal Trophoblast Glycoprotein, M6P1) (FITC) |
|||
| MBS6148618-01mL | MyBiosource | 0.1(mL | EUR 875 |
Oncofetal Antigen 5T4 (TPBG, Trophoblast Glycoprotein, 5T4 Oncofetal antigen, 5T4 Oncofetal Trophoblast Glycoprotein, M6P1) (FITC) |
|||
| MBS6148618-5x01mL | MyBiosource | 5x0.1mL | EUR 3800 |
Oncofetal Antigen 5T4 (TPBG, Trophoblast Glycoprotein, 5T4 Oncofetal antigen, 5T4 Oncofetal Trophoblast Glycoprotein, M6P1) (AP) |
|||
| MBS6388008-01mL | MyBiosource | 0.1mL | EUR 920 |
Oncofetal Antigen 5T4 (TPBG, Trophoblast Glycoprotein, 5T4 Oncofetal antigen, 5T4 Oncofetal Trophoblast Glycoprotein, M6P1) (AP) |
|||
| MBS6388008-5x01mL | MyBiosource | 5x0.1mL | EUR 3990 |
Oncofetal Antigen 5T4 (TPBG, Trophoblast Glycoprotein, 5T4 Oncofetal antigen, 5T4 Oncofetal Trophoblast Glycoprotein, M6P1) APC |
|||
| MBS6388009-01mL | MyBiosource | 0.1mL | EUR 920 |
Oncofetal Antigen 5T4 (TPBG, Trophoblast Glycoprotein, 5T4 Oncofetal antigen, 5T4 Oncofetal Trophoblast Glycoprotein, M6P1) APC |
|||
| MBS6388009-5x01mL | MyBiosource | 5x0.1mL | EUR 3990 |
Oncofetal Antigen 5T4 (TPBG, Trophoblast Glycoprotein, 5T4 Oncofetal antigen, 5T4 Oncofetal Trophoblast Glycoprotein, M6P1) (FITC) |
|||
| MBS6388011-01mL | MyBiosource | 0.1mL | EUR 920 |
Oncofetal Antigen 5T4 (TPBG, Trophoblast Glycoprotein, 5T4 Oncofetal antigen, 5T4 Oncofetal Trophoblast Glycoprotein, M6P1) (FITC) |
|||
| MBS6388011-5x01mL | MyBiosource | 5x0.1mL | EUR 3990 |
Oncofetal Antigen 5T4 (TPBG, Trophoblast Glycoprotein, 5T4 Oncofetal antigen, 5T4 Oncofetal Trophoblast Glycoprotein, M6P1) (HRP) |
|||
| MBS6388012-01mL | MyBiosource | 0.1mL | EUR 920 |
Oncofetal Antigen 5T4 (TPBG, Trophoblast Glycoprotein, 5T4 Oncofetal antigen, 5T4 Oncofetal Trophoblast Glycoprotein, M6P1) (HRP) |
|||
| MBS6388012-5x01mL | MyBiosource | 5x0.1mL | EUR 3990 |
Oncofetal Antigen 5T4 (TPBG, Trophoblast Glycoprotein, 5T4 Oncofetal antigen, 5T4 Oncofetal Trophoblast Glycoprotein, M6P1) (PE) |
|||
| MBS6388018-01mL | MyBiosource | 0.1mL | EUR 920 |
Oncofetal Antigen 5T4 (TPBG, Trophoblast Glycoprotein, 5T4 Oncofetal antigen, 5T4 Oncofetal Trophoblast Glycoprotein, M6P1) (PE) |
|||
| MBS6388018-5x01mL | MyBiosource | 5x0.1mL | EUR 3990 |
Oncofetal Antigen 5T4, ID (TPBG, Trophoblast Glycoprotein, 5T4 Oncofetal antigen, 5T4 Oncofetal Trophoblast Glycoprotein, M6P1) |
|||
| MBS646659-02mL | MyBiosource | 0.2mL | EUR 695 |
Oncofetal Antigen 5T4, ID (TPBG, Trophoblast Glycoprotein, 5T4 Oncofetal antigen, 5T4 Oncofetal Trophoblast Glycoprotein, M6P1) |
|||
| MBS646659-5x02mL | MyBiosource | 5x0.2mL | EUR 2975 |
Oncofetal Antigen 5T4 (TPBG, Trophoblast Glycoprotein, 5T4 Oncofetal antigen, 5T4 Oncofetal Trophoblast Glycoprotein, M6P1) (HRP) |
|||
| MBS6153921-01mL | MyBiosource | 0.1(mL | EUR 875 |
Oncofetal Antigen 5T4 (TPBG, Trophoblast Glycoprotein, 5T4 Oncofetal antigen, 5T4 Oncofetal Trophoblast Glycoprotein, M6P1) (HRP) |
|||
| MBS6153921-5x01mL | MyBiosource | 5x0.1mL | EUR 3800 |
Oncofetal Antigen 5T4 (TPBG, Trophoblast Glycoprotein, 5T4 Oncofetal antigen, 5T4 Oncofetal Trophoblast Glycoprotein, M6P1) (PE) |
|||
| MBS6159224-01mL | MyBiosource | 0.1(mL | EUR 875 |
Oncofetal Antigen 5T4 (TPBG, Trophoblast Glycoprotein, 5T4 Oncofetal antigen, 5T4 Oncofetal Trophoblast Glycoprotein, M6P1) (PE) |
|||
| MBS6159224-5x01mL | MyBiosource | 5x0.1mL | EUR 3800 |
VZV Ag gE (Ellen) |
|||
| GWB-EB9306 | GenWay Biotech | 1 mg | Ask for price |
Sudan Ebola Virus Glycoprotein (GP) |
|||
| REC32011-100 | The Native Antigen Company | 0.1 | EUR 452.9 |
|
Description: Recombinant Sudan ebola virus glycoprotein soluble domain (AA32-649) produced in HEK293 cells and purified from culture supernatant by immobilized metal affinity chromatography. The protein is cleaved by furin into GP1 and GP2 upon expression. This protein is predominantly monomeric |
|||
Sudan Ebola Virus Glycoprotein (GP) |
|||
| REC32011-500 | The Native Antigen Company | 0.5 | EUR 1924.78 |
|
Description: Recombinant Sudan ebola virus glycoprotein soluble domain (AA32-649) produced in HEK293 cells and purified from culture supernatant by immobilized metal affinity chromatography. The protein is cleaved by furin into GP1 and GP2 upon expression. This protein is predominantly monomeric |
|||
Mouse Anti Ross River Virus E2 Glycoprotein (D7) |
|||
| MAB12370-100 | The Native Antigen Company | 0.1 | EUR 332.98 |
|
Description: Mouse monoclonal antibody specific for Ross River virus E2 Glycoprotein (D7) |
|||
Oncofetal Antigen 5T4 (TPBG, Trophoblast Glycoprotein, 5T4 Oncofetal antigen, 5T4 Oncofetal Trophoblast Glycoprotein, M6P1) (Biotin) |
|||
| MBS6143315-01mL | MyBiosource | 0.1(mL | EUR 875 |
Oncofetal Antigen 5T4 (TPBG, Trophoblast Glycoprotein, 5T4 Oncofetal antigen, 5T4 Oncofetal Trophoblast Glycoprotein, M6P1) (Biotin) |
|||
| MBS6143315-5x01mL | MyBiosource | 5x0.1mL | EUR 3800 |
Oncofetal Antigen 5T4 (TPBG, Trophoblast Glycoprotein, 5T4 Oncofetal antigen, 5T4 Oncofetal Trophoblast Glycoprotein, M6P1) (Biotin) |
|||
| MBS6388010-01mL | MyBiosource | 0.1mL | EUR 920 |
Oncofetal Antigen 5T4 (TPBG, Trophoblast Glycoprotein, 5T4 Oncofetal antigen, 5T4 Oncofetal Trophoblast Glycoprotein, M6P1) (Biotin) |
|||
| MBS6388010-5x01mL | MyBiosource | 5x0.1mL | EUR 3990 |
Oncofetal Antigen 5T4, ID (TPBG, Trophoblast Glycoprotein, 5T4 Oncofetal antigen, 5T4 Oncofetal Trophoblast Glycoprotein, M6P1) (AP) |
|||
| MBS6357582-02mL | MyBiosource | 0.2mL | EUR 980 |
Oncofetal Antigen 5T4, ID (TPBG, Trophoblast Glycoprotein, 5T4 Oncofetal antigen, 5T4 Oncofetal Trophoblast Glycoprotein, M6P1) (AP) |
|||
| MBS6357582-5x02mL | MyBiosource | 5x0.2mL | EUR 4250 |
Oncofetal Antigen 5T4, ID (TPBG, Trophoblast Glycoprotein, 5T4 Oncofetal antigen, 5T4 Oncofetal Trophoblast Glycoprotein, M6P1) (APC) |
|||
| MBS6357583-02mL | MyBiosource | 0.2mL | EUR 980 |
Oncofetal Antigen 5T4, ID (TPBG, Trophoblast Glycoprotein, 5T4 Oncofetal antigen, 5T4 Oncofetal Trophoblast Glycoprotein, M6P1) (APC) |
|||
| MBS6357583-5x02mL | MyBiosource | 5x0.2mL | EUR 4250 |
Oncofetal Antigen 5T4, ID (TPBG, Trophoblast Glycoprotein, 5T4 Oncofetal antigen, 5T4 Oncofetal Trophoblast Glycoprotein, M6P1) (FITC) |
|||
| MBS6357585-02mL | MyBiosource | 0.2mL | EUR 980 |
Oncofetal Antigen 5T4, ID (TPBG, Trophoblast Glycoprotein, 5T4 Oncofetal antigen, 5T4 Oncofetal Trophoblast Glycoprotein, M6P1) (FITC) |
|||
| MBS6357585-5x02mL | MyBiosource | 5x0.2mL | EUR 4250 |
Oncofetal Antigen 5T4, ID (TPBG, Trophoblast Glycoprotein, 5T4 Oncofetal antigen, 5T4 Oncofetal Trophoblast Glycoprotein, M6P1) (PE) |
|||
| MBS6357592-02mL | MyBiosource | 0.2mL | EUR 980 |
Oncofetal Antigen 5T4, ID (TPBG, Trophoblast Glycoprotein, 5T4 Oncofetal antigen, 5T4 Oncofetal Trophoblast Glycoprotein, M6P1) (PE) |
|||
| MBS6357592-5x02mL | MyBiosource | 5x0.2mL | EUR 4250 |
Varicella Zoster Virus Glycoprotein I (VZV gpl), Antibody |
|||
| GWB-CB4177 | GenWay Biotech | 0.1 mg | Ask for price |
Recombinant Pseudorabies Virus Glycoprotein B Antigen |
|||
| HCV-231 | Creative BioMart | 1 vial | EUR 1118.4 |
|
Description: Protein |
|||
Recombinant Pseudorabies Virus Glycoprotein E Antigen |
|||
| VAC-0232 | Creative BioMart | 0.5ml | EUR 1598.4 |
|
Description: Protein |
|||
Oncofetal Antigen 5T4 (TPBG, Trophoblast Glycoprotein, 5T4 Oncofetal antigen, 5T4 Oncofetal Trophoblast Glycoprotein, M6P1) (MaxLight 405) |
|||
| MBS6388013-01mL | MyBiosource | 0.1mL | EUR 920 |
Oncofetal Antigen 5T4 (TPBG, Trophoblast Glycoprotein, 5T4 Oncofetal antigen, 5T4 Oncofetal Trophoblast Glycoprotein, M6P1) (MaxLight 405) |
|||
| MBS6388013-5x01mL | MyBiosource | 5x0.1mL | EUR 3990 |
Oncofetal Antigen 5T4 (TPBG, Trophoblast Glycoprotein, 5T4 Oncofetal antigen, 5T4 Oncofetal Trophoblast Glycoprotein, M6P1) (MaxLight 490) |
|||
| MBS6388014-01mL | MyBiosource | 0.1mL | EUR 920 |
Oncofetal Antigen 5T4 (TPBG, Trophoblast Glycoprotein, 5T4 Oncofetal antigen, 5T4 Oncofetal Trophoblast Glycoprotein, M6P1) (MaxLight 490) |
|||
| MBS6388014-5x01mL | MyBiosource | 5x0.1mL | EUR 3990 |
Oncofetal Antigen 5T4 (TPBG, Trophoblast Glycoprotein, 5T4 Oncofetal antigen, 5T4 Oncofetal Trophoblast Glycoprotein, M6P1) (MaxLight 550) |
|||
| MBS6388015-01mL | MyBiosource | 0.1mL | EUR 920 |
Oncofetal Antigen 5T4 (TPBG, Trophoblast Glycoprotein, 5T4 Oncofetal antigen, 5T4 Oncofetal Trophoblast Glycoprotein, M6P1) (MaxLight 550) |
|||
| MBS6388015-5x01mL | MyBiosource | 5x0.1mL | EUR 3990 |
Oncofetal Antigen 5T4 (TPBG, Trophoblast Glycoprotein, 5T4 Oncofetal antigen, 5T4 Oncofetal Trophoblast Glycoprotein, M6P1) (MaxLight 650) |
|||
| MBS6388016-01mL | MyBiosource | 0.1mL | EUR 920 |
Oncofetal Antigen 5T4 (TPBG, Trophoblast Glycoprotein, 5T4 Oncofetal antigen, 5T4 Oncofetal Trophoblast Glycoprotein, M6P1) (MaxLight 650) |
|||
| MBS6388016-5x01mL | MyBiosource | 5x0.1mL | EUR 3990 |
Oncofetal Antigen 5T4 (TPBG, Trophoblast Glycoprotein, 5T4 Oncofetal antigen, 5T4 Oncofetal Trophoblast Glycoprotein, M6P1) (MaxLight 750) |
|||
| MBS6388017-01mL | MyBiosource | 0.1mL | EUR 920 |
Oncofetal Antigen 5T4 (TPBG, Trophoblast Glycoprotein, 5T4 Oncofetal antigen, 5T4 Oncofetal Trophoblast Glycoprotein, M6P1) (MaxLight 750) |
|||
| MBS6388017-5x01mL | MyBiosource | 5x0.1mL | EUR 3990 |
Oncofetal Antigen 5T4, ID (TPBG, Trophoblast Glycoprotein, 5T4 Oncofetal antigen, 5T4 Oncofetal Trophoblast Glycoprotein, M6P1) (Biotin) |
|||
| MBS6357584-02mL | MyBiosource | 0.2mL | EUR 980 |
Oncofetal Antigen 5T4, ID (TPBG, Trophoblast Glycoprotein, 5T4 Oncofetal antigen, 5T4 Oncofetal Trophoblast Glycoprotein, M6P1) (Biotin) |
|||
| MBS6357584-5x02mL | MyBiosource | 5x0.2mL | EUR 4250 |
Oncofetal Antigen 5T4 (TPBG, Trophoblast Glycoprotein, 5T4 Oncofetal antigen, 5T4 Oncofetal Trophoblast Glycoprotein, M6P1) (MaxLight 490) |
|||
| MBS6202248-01mL | MyBiosource | 0.1(mL | EUR 875 |
Oncofetal Antigen 5T4 (TPBG, Trophoblast Glycoprotein, 5T4 Oncofetal antigen, 5T4 Oncofetal Trophoblast Glycoprotein, M6P1) (MaxLight 490) |
|||
| MBS6202248-5x01mL | MyBiosource | 5x0.1mL | EUR 3800 |
Oncofetal Antigen 5T4, ID (TPBG, Trophoblast Glycoprotein, 5T4 Oncofetal antigen, 5T4 Oncofetal Trophoblast Glycoprotein, M6P1) (Biotin) |
|||
| MBS621263-005mg | MyBiosource | 0.05mg | EUR 985 |
Oncofetal Antigen 5T4, ID (TPBG, Trophoblast Glycoprotein, 5T4 Oncofetal antigen, 5T4 Oncofetal Trophoblast Glycoprotein, M6P1) (Biotin) |
|||
| MBS621263-5x005mg | MyBiosource | 5x0.05mg | EUR 4280 |
Oncofetal Antigen 5T4 (TPBG, Trophoblast Glycoprotein, 5T4 Oncofetal antigen, 5T4 Oncofetal Trophoblast Glycoprotein, M6P1) (MaxLight 550) |
|||
| MBS6212923-01mL | MyBiosource | 0.1(mL | EUR 875 |
Oncofetal Antigen 5T4 (TPBG, Trophoblast Glycoprotein, 5T4 Oncofetal antigen, 5T4 Oncofetal Trophoblast Glycoprotein, M6P1) (MaxLight 550) |
|||
| MBS6212923-5x01mL | MyBiosource | 5x0.1mL | EUR 3800 |
Oncofetal Antigen 5T4 (TPBG, Trophoblast Glycoprotein, 5T4 Oncofetal antigen, 5T4 Oncofetal Trophoblast Glycoprotein, M6P1) (MaxLight 405) |
|||
| MBS6191573-01mL | MyBiosource | 0.1(mL | EUR 875 |
Oncofetal Antigen 5T4 (TPBG, Trophoblast Glycoprotein, 5T4 Oncofetal antigen, 5T4 Oncofetal Trophoblast Glycoprotein, M6P1) (MaxLight 405) |
|||
| MBS6191573-5x01mL | MyBiosource | 5x0.1mL | EUR 3800 |
Oncofetal Antigen 5T4 (TPBG, Trophoblast Glycoprotein, 5T4 Oncofetal antigen, 5T4 Oncofetal Trophoblast Glycoprotein, M6P1) (MaxLight 650) |
|||
| MBS6223598-01mL | MyBiosource | 0.1(mL | EUR 875 |
Oncofetal Antigen 5T4 (TPBG, Trophoblast Glycoprotein, 5T4 Oncofetal antigen, 5T4 Oncofetal Trophoblast Glycoprotein, M6P1) (MaxLight 650) |
|||
| MBS6223598-5x01mL | MyBiosource | 5x0.1mL | EUR 3800 |
Oncofetal Antigen 5T4 (TPBG, Trophoblast Glycoprotein, 5T4 Oncofetal antigen, 5T4 Oncofetal Trophoblast Glycoprotein, M6P1) (MaxLight 750) |
|||
| MBS6234273-01mL | MyBiosource | 0.1(mL | EUR 875 |
Oncofetal Antigen 5T4 (TPBG, Trophoblast Glycoprotein, 5T4 Oncofetal antigen, 5T4 Oncofetal Trophoblast Glycoprotein, M6P1) (MaxLight 750) |
|||
| MBS6234273-5x01mL | MyBiosource | 5x0.1mL | EUR 3800 |
Mouse Anti-Herpes Simplex Virus Glycoprotein D Antibody (E317) |
|||
| MAB12121-200 | The Native Antigen Company | 0.2 | EUR 884.52 |
|
Description: Mouse monoclonal antibody specific for HSV Glycoprotein D |
|||
VZV gE (Ellen) Protein |
|||
| abx060677-1mg | Abbexa | 1 mg | EUR 1888.8 |
VZV gE (Ellen) Protein |
|||
| abx060677-100g | Abbexa | 100 µg | Ask for price |
VZV gE (Ellen) Protein |
|||
| abx060677-10g | Abbexa | 10 µg | EUR 1787.5 |
VZV gE (Ellen) Protein |
|||
| abx060677-50g | Abbexa | 50 µg | Ask for price |
Oncofetal Antigen 5T4, ID (TPBG, Trophoblast Glycoprotein, 5T4 Oncofetal antigen, 5T4 Oncofetal Trophoblast Glycoprotein, M6P1) (MaxLight 405) |
|||
| MBS6357587-01mL | MyBiosource | 0.1mL | EUR 980 |
Oncofetal Antigen 5T4, ID (TPBG, Trophoblast Glycoprotein, 5T4 Oncofetal antigen, 5T4 Oncofetal Trophoblast Glycoprotein, M6P1) (MaxLight 405) |
|||
| MBS6357587-5x01mL | MyBiosource | 5x0.1mL | EUR 4250 |
Oncofetal Antigen 5T4, ID (TPBG, Trophoblast Glycoprotein, 5T4 Oncofetal antigen, 5T4 Oncofetal Trophoblast Glycoprotein, M6P1) (MaxLight 490) |
|||
| MBS6357588-01mL | MyBiosource | 0.1mL | EUR 980 |
Oncofetal Antigen 5T4, ID (TPBG, Trophoblast Glycoprotein, 5T4 Oncofetal antigen, 5T4 Oncofetal Trophoblast Glycoprotein, M6P1) (MaxLight 490) |
|||
| MBS6357588-5x01mL | MyBiosource | 5x0.1mL | EUR 4250 |
Oncofetal Antigen 5T4, ID (TPBG, Trophoblast Glycoprotein, 5T4 Oncofetal antigen, 5T4 Oncofetal Trophoblast Glycoprotein, M6P1) (MaxLight 550) |
|||
| MBS6357589-01mL | MyBiosource | 0.1mL | EUR 980 |
Oncofetal Antigen 5T4, ID (TPBG, Trophoblast Glycoprotein, 5T4 Oncofetal antigen, 5T4 Oncofetal Trophoblast Glycoprotein, M6P1) (MaxLight 550) |
|||
| MBS6357589-5x01mL | MyBiosource | 5x0.1mL | EUR 4250 |
Oncofetal Antigen 5T4, ID (TPBG, Trophoblast Glycoprotein, 5T4 Oncofetal antigen, 5T4 Oncofetal Trophoblast Glycoprotein, M6P1) (MaxLight 650) |
|||
| MBS6357590-01mL | MyBiosource | 0.1mL | EUR 980 |
Oncofetal Antigen 5T4, ID (TPBG, Trophoblast Glycoprotein, 5T4 Oncofetal antigen, 5T4 Oncofetal Trophoblast Glycoprotein, M6P1) (MaxLight 650) |
|||
| MBS6357590-5x01mL | MyBiosource | 5x0.1mL | EUR 4250 |
Oncofetal Antigen 5T4, ID (TPBG, Trophoblast Glycoprotein, 5T4 Oncofetal antigen, 5T4 Oncofetal Trophoblast Glycoprotein, M6P1) (MaxLight 750) |
|||
| MBS6357591-01mL | MyBiosource | 0.1mL | EUR 980 |
Oncofetal Antigen 5T4, ID (TPBG, Trophoblast Glycoprotein, 5T4 Oncofetal antigen, 5T4 Oncofetal Trophoblast Glycoprotein, M6P1) (MaxLight 750) |
|||
| MBS6357591-5x01mL | MyBiosource | 5x0.1mL | EUR 4250 |
Human Antigen-presenting glycoprotein CD1d (CD1D) |
|||
| 1-CSB-EP004892HU | Cusabio |
|
|
|
Description: Recombinant Human Antigen-presenting glycoprotein CD1d(CD1D),partial expressed in E.coli |
|||
Recombinant Ebola Zaire Glycoprotein Antigen, His-tagged |
|||
| VAC-0193 | Creative BioMart | 0.5ml | EUR 1598.4 |
|
Description: Protein |
|||
Oncofetal Antigen 5T4, ID (TPBG, Trophoblast Glycoprotein, 5T4 Oncofetal antigen, 5T4 Oncofetal Trophoblast Glycoprotein, M6P1) (Azide free) (HRP) |
|||
| MBS6357586-02mL | MyBiosource | 0.2mL | EUR 980 |
Oncofetal Antigen 5T4, ID (TPBG, Trophoblast Glycoprotein, 5T4 Oncofetal antigen, 5T4 Oncofetal Trophoblast Glycoprotein, M6P1) (Azide free) (HRP) |
|||
| MBS6357586-5x02mL | MyBiosource | 5x0.2mL | EUR 4250 |
CD5 (CD5 antigen, p56 62, LEU1, Ly12, LyA, Lymphocyte antigen T1/Leu-1, Lymphocyte GlycoProtein T1/Leu1, T-cell surface GlycoProtein CD5) (AP) |
|||
| MBS6123994-01mL | MyBiosource | 0.1(mL | EUR 935 |
CD5 (CD5 antigen, p56 62, LEU1, Ly12, LyA, Lymphocyte antigen T1/Leu-1, Lymphocyte GlycoProtein T1/Leu1, T-cell surface GlycoProtein CD5) (AP) |
|||
| MBS6123994-5x01mL | MyBiosource | 5x0.1mL | EUR 4050 |
CD5 (CD5 antigen, p56 62, LEU1, Ly12, LyA, Lymphocyte antigen T1/Leu-1, Lymphocyte GlycoProtein T1/Leu1, T-cell surface GlycoProtein CD5) (PE) |
|||
| MBS6123999-01mL | MyBiosource | 0.1(mL | EUR 935 |
CD5 (CD5 antigen, p56 62, LEU1, Ly12, LyA, Lymphocyte antigen T1/Leu-1, Lymphocyte GlycoProtein T1/Leu1, T-cell surface GlycoProtein CD5) (PE) |
|||
| MBS6123999-5x01mL | MyBiosource | 5x0.1mL | EUR 4050 |
CD5 (CD5 antigen (p56 62), LEU1, Ly12, LyA, Lymphocyte antigen T1/Leu-1, Lymphocyte glycoprotein T1/Leu1, T-cell surface glycoprotein CD5) (AP) |
|||
| MBS6122789-01mL | MyBiosource | 0.1(mL | EUR 935 |